Hetero Drugs Limited
Hetero Drugs Limited (India) holds 117 active US FDA Type II Drug Master Files and 26 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Hetero Drugs Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/hetero-drugs-limited
Overview
Hetero Drugs Limited is a leading Indian pharmaceutical company known for manufacturing a wide range of generic drugs, active pharmaceutical ingredients (APIs), and finished dosages. With a strong emphasis on research and development, Hetero focuses on delivering high-quality and affordable medicines to patients worldwide.
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Hetero Drugs Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Hetero Drugs Limited holds 117 active (143 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- DABIGATRAN ETEXILATE MESYLATE, PROCESS-IIActive2026-08-03
- SEMAGLUTIDEActive2026-07-17
- CASPOFUNGIN ACETATEActive2026-05-29
- ELIGLUSTAT TARTRATEActive2025-12-13
- MITAPIVAT SULFATEActive2025-10-10
- VASOPRESSIN USPActive2025-06-30
- ATOVAQUONE (FORM-A), PROCESS IIActive2024-12-31
- RIFAXIMINActive2024-12-31
- BUPROPION HYDROBROMIDEActive2024-10-18
- MICAFUNGIN SODIUMActive2024-08-16
- IRON SUCROSEActive2024-03-28
- SELENIOUS ACIDActive2024-01-25
- DESVENLAFAXINE SUCCINATEActive2023-07-01
- MIRTAZAPINEActive2023-05-15
- SOLRIAMFETOL HYDROCHLORIDEActive2023-04-18
- LISINOPRIL PROCESS-IIIActive2023-03-03
- RIVAROXABANActive2023-02-23
- RALTEGRAVIR POTASSIUM (FORM-III)Active2022-12-10
- DEXLANSOPRAZOLE SESQUIHYDRATEActive2022-11-25
- AMIFAMPRIDINE PHOSPHATEActive2022-09-14
- ISOTRETINOINActive2022-03-22
- SODIUM ZIRCONIUM CYCLOSILICATEActive2022-03-17
- VENLAFAXINE HYDROCHLORIDEActive2021-12-13
- INDOMETHACINActive2021-10-23
- RUFINAMIDEActive2021-08-18
- MEXILETINE HYDROCHLORIDEActive2021-06-04
- FAMOTIDINEActive2021-04-30
- ALLOPURINOLActive2020-12-21
- DEUTETRABENAZINEActive2020-11-18
- GLYCEROL PHENYL BUTYRATEActive2020-04-21
- VARENICLINE TARTRATEActive2019-10-30
- METOPROLOL SUCCINATEActive2019-07-17
- DEXLANSOPRAZOLEActive2019-06-10
- IVABRADINE HYDROCHLORIDEActive2018-12-12
- VIGABATRINActive2018-09-28
- DIVALPROEX SODIUMActive2018-09-20
- ZAFIRLUKAST (AMORPHOUS)Active2018-02-12
- APREMILAST (FORM-B)Active2017-12-07
- GABAPENTIN (PROCESS-II)Active2017-07-24
- NEBIVOLOL HYDROCHLORIDE (PROCESS-II)Active2016-11-02
- SEVELAMER CARBONATEActive2016-06-18
- MIRABEGRON (FORM-B)Active2016-02-16
- CINACALCET HYDROCHLORIDEActive2015-05-19
- RILPIVIRINE HYDROCHLORIDEActive2015-04-16
- DONEPEZIL HYDROCHLORIDE (ANHYDROUS)Active2015-03-18
- ESOMEPRAZOLE MAGNESIUM DIHYDRATE (PROCESS-III)Active2014-10-21
- ROFLUMILASTActive2014-08-27
- DABIGATRAN ETEXILATE MESYLATEActive2014-08-05
- ESOMEPRAZOLE MAGNESIUM TRIHYDRATEActive2014-06-05
- BUPROPION HYDROCHLORIDE (PROCESS-II)Active2014-06-04
Showing the 50 most relevant of 143 Drug Master Files (active first). The full list is in the FDA DMF list.
Registered manufacturing sites (2)
Physical sites registered with the US FDA and resolved to Hetero Drugs Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Hetero Drugs Limited in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Hetero Drugs Limited?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.